StockUnited StatesNasdaqGS

GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

15.52USD

-0.3800 (-2.39%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 15.52

P/E—

Dvd Ind Yld—

P/B4.37

P/S61.3

Curr EV/T12M EBITDA-6.4

Mkt Cap (USD)2.0B

Curr EV (USD)1.6B

Per Share Data

EPS T12M-5.15

DPS—

Bk Val Per Sh3.56

Rev/Sh0.25

Cash/Sh3.56

Curr Shares Out128.4M

FCF/Sh-1.92

Cash Flow Analysis

P/CF-8.3

Curr P/FCF-8.1

CF/NI1.1

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales-739.6%

Eff Interest Rate1.6%

Growth Potential

Dil EPS 1Y Gr—

Cap 1Y Gr-41.8%

BPS 1Y Gr—

R&D To Sales704.0%

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr—

Assets 1Y Gr—

Profitability

EBITDA-0.2B

EBIT-0.2B

Operating Margin-751.2%

Pretax Margin-707.5%

Net Margin-685.9%

ROA-39.7%

ROE2979.4%

ROC—

Asset Turnover0.06

Structure

Current Ratio8.30

Quick Ratio8.08

Debt/Assets11.1%

Debt/Com Eq13.7%

Net Debt/EBITDA0.32

Tot Debt/Capital12.1%

Gross Margin0.0%

EBIT/Int Exp-241.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.